DONOR SITE MORBIDITY OF FIBULAR FLAP

Objective: To present the early and late outcomes related to donor site morbidity of Free Fibular Flap. Study Design: Prospective observational study. Place and Duration of Study: Plastic surgery department, Combined Military Hospital Rawalpindi, from Jan 2009 to Jan 2020. Methodology: In t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ghazanfar Ali, Abdul Majid, Danish Almas, Shahid Hameed, Rizwan Aslam, Zubair Ahmad Khan
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2021
Materias:	donor site free fibula morbidity Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/17b06b5311c049b687584f4445e392b6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:17b06b5311c049b687584f4445e392b6
record_format	dspace
spelling	oai:doaj.org-article:17b06b5311c049b687584f4445e392b62021-12-02T17:10:36ZDONOR SITE MORBIDITY OF FIBULAR FLAP0030-96482411-884210.51253/pafmj.v71i2.5220https://doaj.org/article/17b06b5311c049b687584f4445e392b62021-04-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/5220https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To present the early and late outcomes related to donor site morbidity of Free Fibular Flap. Study Design: Prospective observational study. Place and Duration of Study: Plastic surgery department, Combined Military Hospital Rawalpindi, from Jan 2009 to Jan 2020. Methodology: In total 361 patients were enrolled for the study through consecutive purposive sampling. All patients requiring free fibula flap for reconstruction of the defect were included in the study. However, the patients with Diabetes Mellitus, Smoking or peripheral vascular disease were excluded from the study. The patients were asked to visit on second week and then at three months for late outcomes. The results were entered SPSS-24 for analysis and interpretation of data. Results: Out of total 361 patients enrolled for study 293 (81.16%) were male and 68 (18.83%) were female. The men age was 51.43 years SD 14.6 (range 4 year to 68 years). In early outcomes, graft loss 29 (8.03%) and sensory deficit 19 (5.26%), are the commonest adverse outcomes. Results of late follow up revealed chronic pain in 29 (8.03%), ankle instability in 24 (6.64%), gait abnormality in 29 (8.76%) and claw toe in 33 (9.14%) patients. The American Orthopedic Foot and Ankle Society (AOFAS) score was 88.45%. Majority (52.63%) patients were very satisfied. Conclusion: The free Fibula is excellent choice for reconstruction of a wide range of osseous defects with minimum donor site morbidity and high satisfaction rate among the patients. Keywords:Ghazanfar AliAbdul MajidDanish AlmasShahid HameedRizwan AslamZubair Ahmad KhanArmy Medical College Rawalpindiarticledonor sitefree fibulamorbidityMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 71, Iss 2, Pp 387-91 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	donor site free fibula morbidity Medicine R Medicine (General) R5-920
spellingShingle	donor site free fibula morbidity Medicine R Medicine (General) R5-920 Ghazanfar Ali Abdul Majid Danish Almas Shahid Hameed Rizwan Aslam Zubair Ahmad Khan DONOR SITE MORBIDITY OF FIBULAR FLAP
description	Objective: To present the early and late outcomes related to donor site morbidity of Free Fibular Flap. Study Design: Prospective observational study. Place and Duration of Study: Plastic surgery department, Combined Military Hospital Rawalpindi, from Jan 2009 to Jan 2020. Methodology: In total 361 patients were enrolled for the study through consecutive purposive sampling. All patients requiring free fibula flap for reconstruction of the defect were included in the study. However, the patients with Diabetes Mellitus, Smoking or peripheral vascular disease were excluded from the study. The patients were asked to visit on second week and then at three months for late outcomes. The results were entered SPSS-24 for analysis and interpretation of data. Results: Out of total 361 patients enrolled for study 293 (81.16%) were male and 68 (18.83%) were female. The men age was 51.43 years SD 14.6 (range 4 year to 68 years). In early outcomes, graft loss 29 (8.03%) and sensory deficit 19 (5.26%), are the commonest adverse outcomes. Results of late follow up revealed chronic pain in 29 (8.03%), ankle instability in 24 (6.64%), gait abnormality in 29 (8.76%) and claw toe in 33 (9.14%) patients. The American Orthopedic Foot and Ankle Society (AOFAS) score was 88.45%. Majority (52.63%) patients were very satisfied. Conclusion: The free Fibula is excellent choice for reconstruction of a wide range of osseous defects with minimum donor site morbidity and high satisfaction rate among the patients. Keywords:
format	article
author	Ghazanfar Ali Abdul Majid Danish Almas Shahid Hameed Rizwan Aslam Zubair Ahmad Khan
author_facet	Ghazanfar Ali Abdul Majid Danish Almas Shahid Hameed Rizwan Aslam Zubair Ahmad Khan
author_sort	Ghazanfar Ali
title	DONOR SITE MORBIDITY OF FIBULAR FLAP
title_short	DONOR SITE MORBIDITY OF FIBULAR FLAP
title_full	DONOR SITE MORBIDITY OF FIBULAR FLAP
title_fullStr	DONOR SITE MORBIDITY OF FIBULAR FLAP
title_full_unstemmed	DONOR SITE MORBIDITY OF FIBULAR FLAP
title_sort	donor site morbidity of fibular flap
publisher	Army Medical College Rawalpindi
publishDate	2021
url	https://doaj.org/article/17b06b5311c049b687584f4445e392b6
work_keys_str_mv	AT ghazanfarali donorsitemorbidityoffibularflap AT abdulmajid donorsitemorbidityoffibularflap AT danishalmas donorsitemorbidityoffibularflap AT shahidhameed donorsitemorbidityoffibularflap AT rizwanaslam donorsitemorbidityoffibularflap AT zubairahmadkhan donorsitemorbidityoffibularflap
_version_	1718381484476203008

DONOR SITE MORBIDITY OF FIBULAR FLAP

Ejemplares similares